These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8569052)

  • 1. Increase in vascular sensitivity to angiotensin II and norepinephrine after four-day infusion of 0.3 M sodium chloride in conscious kininogen-deficient brown Norway Katholiek rats.
    Majima M; Adachi K; Kuribayashi Y; Mizogami S; Katori M
    Jpn J Pharmacol; 1995 Oct; 69(2):149-58. PubMed ID: 8569052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the renal kallikrein-kinin system in the development of hypertension.
    Katori M; Majima M
    Immunopharmacology; 1997 Jun; 36(2-3):237-42. PubMed ID: 9228552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High sensitivity to salt in kininogen-deficient brown Norway Katholiek rats.
    Majima M; Yoshida O; Mihara H; Muto T; Mizogami S; Kuribayashi Y; Katori M; Oh-ishi S
    Hypertension; 1993 Nov; 22(5):705-14. PubMed ID: 7693588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertension induced by a nonpressor dose of angiotensin II in kininogen-deficient rats.
    Majima M; Mizogami S; Kuribayashi Y; Katori M; Oh-ishi S
    Hypertension; 1994 Jul; 24(1):111-9. PubMed ID: 8020999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crucial suppressive role of renal kallikrein-kinin system in development of salt-sensitive hypertension.
    Katori M; Majima M; Hayashi I
    Biol Res; 1998; 31(3):143-9. PubMed ID: 9830501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a neutral endopeptidase inhibitor, BP102, on the development of deoxycorticosterone acetate-salt hypertension in kininogen-deficient Brown Norway Katholiek rats.
    Nakajima S; Majima M; Ito H; Hayashi I; Yajima Y; Katori M
    Int J Tissue React; 1998; 20(2):45-56. PubMed ID: 9638501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host stromal bradykinin B2 receptor signaling facilitates tumor-associated angiogenesis and tumor growth.
    Ikeda Y; Hayashi I; Kamoshita E; Yamazaki A; Endo H; Ishihara K; Yamashina S; Tsutsumi Y; Matsubara H; Majima M
    Cancer Res; 2004 Aug; 64(15):5178-85. PubMed ID: 15289322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ebelactone B, an inhibitor of urinary carboxypeptidase Y-like kininase, prevents the development of deoxycorticosterone acetate-salt hypertension in rats.
    Majima M; Ikeda Y; Kuribayashi Y; Mizogami S; Katori M; Aoyagi T
    Eur J Pharmacol; 1995 Sep; 284(1-2):1-11. PubMed ID: 8549611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstration of the third kininogen in high and low molecular weight kininogens-deficient Brown Norway Katholiek rat.
    Hayashi I; Ino T; Kato H; Iwanaga S; Nakano T; Oh-ishi S
    Thromb Res; 1984 Dec; 36(6):509-16. PubMed ID: 6570369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressed angiogenesis in kininogen-deficiencies.
    Hayashi I; Amano H; Yoshida S; Kamata K; Kamata M; Inukai M; Fujita T; Kumagai Y; Furudate S; Majima M
    Lab Invest; 2002 Jul; 82(7):871-80. PubMed ID: 12118089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of T-kininogen in high and low molecular weight kininogens deficient rat (brown Norway Katholiek strain).
    Hayashi I; Oh-ishi S; Kato H; Enjyoji K; Iwanaga S; Nakano T
    Thromb Res; 1985 Aug; 39(3):313-21. PubMed ID: 3850646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of kinin degradation on the luminal side of renal tubules reduces high blood pressure in deoxycorticosterone acetate salt-treated rats.
    Nakajima S; Ito H; Hayashi I; Kuribayashi Y; Okumura T; Yajima Y; Katori M; Majima M
    Clin Exp Pharmacol Physiol; 2000; 27(1-2):80-7. PubMed ID: 10696533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kininogen deficiency in the rat.
    Oh-ishi S; Hayashi I; Yamaki K; Utsunomiya I
    Agents Actions Suppl; 1992; 38 ( Pt 1)():277-91. PubMed ID: 1281609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Essential role of kallikrein-kinin system in suppression of blood pressure rise during the developmental stage of hypertension induced by deoxycorticosterone acetate-salt in rats.
    Katori M; Majima M; Mohsin SS; Hanazuka M; Mizogami S; Oh-ishi S
    Agents Actions Suppl; 1992; 38 ( Pt 3)():235-42. PubMed ID: 1281379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of dextran sulfate sodium-induced colitis in kininogen-deficient rats and non-peptide B2 receptor antagonist-treated rats.
    Kamat K; Hayashi I; Mizuguchi Y; Arai K; Saeki T; Ohno T; Saigenji K; Majima M
    Jpn J Pharmacol; 2002 Sep; 90(1):59-66. PubMed ID: 12396028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the renal kallikrein-kinin system in the development of salt-sensitive hypertension.
    Katori M; Majima M; Hayashi I; Fujita T; Yamanaka M
    Biol Chem; 2001 Jan; 382(1):61-4. PubMed ID: 11258674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Chronic Blockade of the Kallikrein-Kinin System on the Development of Hypertension in Rats.
    Rhaleb NE; Yang XP; Nanba M; Shesely EG; Carretero OA
    Hypertension; 2001 Jan; 37(1):121-128. PubMed ID: 11208766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bradykinin inhibits development of myocardial infarction through B2 receptor signalling by increment of regional blood flow around the ischaemic lesions in rats.
    Ito H; Hayashi I; Izumi T; Majima M
    Br J Pharmacol; 2003 Jan; 138(1):225-33. PubMed ID: 12522094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functionally active high molecular weight-kininogen was found in the liver, but not in the plasma of brown Norway Katholiek rat.
    Hayashi I; Maruhashi J; Oh-ishi S
    Thromb Res; 1989 Oct; 56(2):179-89. PubMed ID: 2617467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct radioimmunoassay for rat high molecular weight kininogen. Measurement of immunoreactive high molecular weight kininogen in normal and kininogen deficient plasma.
    Suzuki H; Bouhnik J; Alhenc-Gelas F; Corvol P; Ménard J
    Agents Actions Suppl; 1987; 22():277-87. PubMed ID: 3481212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.